Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Post by azzymaaon Mar 08, 2022 10:27am
169 Views
Post# 34494967

Serious Answers only

Serious Answers onlyDoes anyone actually believe Promis will achieve success in the Alzheimers field with their Pmn310 antibody? Price is falling sharply and Investors are losing interest. 
With a cool head can someone tell me why they think Promis will become a Multi-Billion dollar Company when they have been in Business for more than 10 Years and are still considered a Penny Stock when other Companies are DECADES ahead of us in Biotechnology. What is stopping Promis to be bought out by another Company, if they had something liable they would have already been bought out. There are so many questions that have no answers. I love money on Biogen and now Promis is dropping even after posting a successfull Press Release. EVERY time they post the SP goes up and falls back down - Pump and Dump. But people on this board have their heads stuck up their behinds so far that they fail to realize this. This stock is a Loser and will always be. Just waitng for another nonsense PR and hopefully the SP will go up and I am selling all my Shares and moving on. 
<< Previous
Bullboard Posts
Next >>